Infective endocarditis resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 127: | Line 127: | ||
{{familytree | | | | | | | | B01 | | | | B01= <div style="float: left; text-align: left; width: 40em; padding:1em;">'''Identify existing risk factors:'''<BR>}} | {{familytree | | | | | | | | B01 | | | | B01= <div style="float: left; text-align: left; width: 40em; padding:1em;">'''Identify existing risk factors:'''<BR>}} | ||
{{familytree | | | | | | | | |!| | | | | }} | {{familytree | | | | | | | | |!| | | | | }} | ||
{{familytree | | | | | | | | A01 | | | | |A01= <div style="float: left; text-align: left; width: 40em; padding:1em;">'''Examine the patient:'''<BR> | |||
{{familytree | | | | | | | | A01 | | | | |A01= <div style="float: left; text-align: left; width: 40em; padding:1em;">'''Examine the patient:'''<BR>}} | </div>}} | ||
Revision as of 16:21, 4 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farman Khan, MD, MRCP [2]; Mohamed Moubarak, M.D. [3]
Definition
Infection of the endothelium of the heart including but not limited to the valves. It can be either acute or subacute. Acute bacterial endocarditis is defined as Infection of normal heart valves with a virulent organism like S. aureus, Group A or other beta-hemolytic streptococci, Streptococcus pneumoniae. Subacute bacterial endocarditis is an indolent infection of abnormal valves with less virulent organism like Streptococcus viridans.
Criteria | Definite Infective Endocarditis According to Modified Duke Criteria |
---|---|
Pathological Criteria |
|
Clinical Criteria |
|
Possible IE |
|
Rejected |
|
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Endocarditis can be a life-threatening condition if it is left untreated, and it must be treated as such irrespective of the causes.
Common Causes
Management
Diagnostic Criteria
Shown below is an algorithm depicting the diagnostic criteria of infective endocarditis based on the 2005 American Heart Association (AHA) technical review and medical position statement regarding guidelines on infective endocarditis.[1]
Duke Criteria | |||||||||||||||||||||||||||||||||||||||||||||||||||
The Duke Clinical Criteria for Infective Endocarditis requires either:
❑ Two major criteria, or ❑ One major and three minor criteria, or ❑ Five minor criteria | |||||||||||||||||||||||||||||||||||||||||||||||||||
Major Criteria | Minor criteria | ||||||||||||||||||||||||||||||||||||||||||||||||||
Positive Blood Culture for Infective Endocarditis
Echocardiographic evidence of endocardial involvement
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic approach
Shown below is an algorithm summarizing the approach to infective endocarditis.
Vital signs
❑ Temperature
- ❑ Fever
- ❑ Wide pulse pressure (sign of aortic insufficiency)
- ❑ Narrow pulse pressure (sign of left ventricular failure)
Skin
❑ Petechiae
❑ Splinter hemorrhages
❑ Osler's nodes
❑ Janeway lesions
Eyes
❑ Conjunctival hemorrhage
❑ Roth's spots in the retina
Heart
Lungs
❑ Rales as a sign of heart failure
Abdomen
❑ Reduced bowel sounds (sign of mesenteric embolization or ileus)
❑ Abdominal pain
- ❑ Flank pain (sign of embolus to the kidney)
- ❑ Left upper quadrant pain (sign of splenic infarct)
Extremities
❑ Janeway lesions (painless hemorrhagic cutaneous lesions on the palms and soles)
❑ Gangrene of fingers
❑ Splinter haemorrhages
❑ Osler's nodes (painful subcutaneous lesions in the distal fingers)
Neurologic
❑ Full neurological exam
- ❑ Focal deficits (suggestive of stroke or brain abscess)}}
Characterize the symptoms
❑ Onset of the symptoms:
❑ Fever | |||||||||||||||||||||||||||||
Identify existing risk factors: | |||||||||||||||||||||||||||||
Examine the patient: | |||||||||||||||||||||||||||||
Order laboratory tests:[2] ❑ WBC
❑ Erythrocyte sedimentation rate
❑ BUN ❑ Cr | |||||||||||||||||||||||||||||
Therapeutic Approach
Shown below an algorithm depicting the general therapeutic approaches of infective endocarditis based on the 2005 American Heart Association (AHA) technical review and medical position statement regarding guidelines on infective endocarditis.[3]
Evaluate the patient | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acute or hemodynamically unstable patient | Subacute hemodynamically stable patient | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stabilize the patient | Wait for blood culture results | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Don`t wait for blood culture results and start empirical antibiotic therapy | Start antibiotic therapy according to the detected pathogen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Streptococci antibiotic regimen | Enterococci antibiotic regimen | Staphylococci antibiotic regimen | HACEK Organisms antibiotic regimen | Culture negative antibiotic regimen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prophylactic Approach
Identify the high risk patients
❑ Prosthetic valves patients
| |||||||||||||||||||||||||||
Do's
Dont's
References
- ↑ Baddour Larry M., Wilson Walter R., Bayer Arnold S., Fowler Vance G. Jr, Bolger Ann F., Levison Matthew E., Ferrieri Patricia, Gerber Michael A., Tani Lloyd Y., Gewitz Michael H., Tong David C., Steckelberg James M., Baltimore Robert S., Shulman Stanford T., Burns Jane C., Falace Donald A., Newburger Jane W., Pallasch Thomas J., Takahashi Masato, Taubert Kathryn A. (2005). "Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association-Executive Summary: Endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): 3167–84. PMID 15956145.
- ↑ Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter
|month=
ignored (help) - ↑ Baddour, LM.; Wilson, WR.; Bayer, AS.; Fowler, VG.; Bolger, AF.; Levison, ME.; Ferrieri, P.; Gerber, MA.; Tani, LY. (2005). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): e394–434. doi:10.1161/CIRCULATIONAHA.105.165564. PMID 15956145. Unknown parameter
|month=
ignored (help)